Keiichirou Morimura
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 25
- Pharmacology top 1%
- Environmental Chemistry top 2%
- Hepatology top 5%
-
- Genomics, phytochemicals, and oxidative stress 15
- Glutathione Transferases and Polymorphisms 7
- DNA Repair Mechanisms 6
-
- Cancer-related Molecular Pathways 12
- Drug Transport and Resistance Mechanisms 8
-
- Bladder and Urothelial Cancer Treatments 12
-
- Synthesis and Biological Evaluation 9
Keiichirou Morimura
93 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 825
- Pharmacology 341
- Environmental Chemistry 330
- Health, Toxicology and Mutagenesis 413
- Hepatology 200
Countries citing papers authored by Keiichirou Morimura
This map shows the geographic impact of Keiichirou Morimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichirou Morimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichirou Morimura more than expected).
Fields of papers citing papers by Keiichirou Morimura
This network shows the impact of papers produced by Keiichirou Morimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichirou Morimura. The network helps show where Keiichirou Morimura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keiichirou Morimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Four resected cases with basaloid carcinoma of esophagus--comparison of 5-FU-related enzymes (thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT)) between basaloid carcinoma and squamous cell carcinoma]. | 2010 | 4 |
| 2 | 2009 | 29 | |
| 3 | 2008 | 130 | |
| 4 | 2008 | 49 | |
| 5 | 2007 | 28 | |
| 6 | 2006 | 287 | |
| 7 | Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice. | 2006 | 6 |
| 8 | 2006 | 7 | |
| 9 | Biphasic effect of alpha benzene hexachloride (α-BHC) on diethylnitrosamine-intiated hepatocarcinogenesis and possible hormesis mechanism in rats. | 2005 | 1 |
| 10 | 2005 | 14 | |
| 11 | 2005 | 13 | |
| 12 | 2005 | 7 | |
| 13 | 2004 | 67 | |
| 14 | 2003 | 6 | |
| 15 | 2003 | 29 | |
| 16 | 2003 | 32 | |
| 17 | 2000 | 37 | |
| 18 | 1999 | 10 | |
| 19 | 1999 | 6 | |
| 20 | 1999 | 9 |
About Keiichirou Morimura
Keiichirou Morimura is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 95 papers that have together received 3.5k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (25 papers), Genomics, phytochemicals, and oxidative stress (15 papers), Cancer-related Molecular Pathways (12 papers), Bladder and Urothelial Cancer Treatments (12 papers), Synthesis and Biological Evaluation (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Glutathione Transferases and Polymorphisms (7 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Cancer Research (825 citations), Pharmacology (341 citations) and Environmental Chemistry (330 citations). Keiichirou Morimura has collaborated with scholars based in Japan, United States and Ukraine. Frequent co-authors include Frank J. Gonzalez, Shoji Fukushima, Hideki Wanibuchi, Yatrik M. Shah, In‐Sook Kim, Jerrold M. Ward, Min Wei, Anna Kinoshita, Jin Seok Kang and Qian Yang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.